Skip to main content
    S

    SkinHealth Systems Inc. (SKIN)

    Official site

    CONSUMER DEFENSIVE • HOUSEHOLD & PERSONAL PRODUCTS • NASDAQ

    $15.05
    -1.26 (-7.73%)

    Market Cap: $106.26M

    Last updated: Nov 17, 2026 at 11:01 AM ET

    SkinHealth Systems Inc. (SKIN) Financials: Revenue, Profit and Cash Flow

    Updated Nov 5, 2026. Financial statements from company filings, amounts in US dollars.

    SkinHealth Systems reported revenue of $300.79M for the fiscal year ended Dec 31, 2025, down 10.0% from the year before. That year, net income was -$9.52M with a net margin of -3.2%, operating cash flow was $37.48M and free cash flow was $37.18M. The quarter ended Sep 30, 2026 had revenue of $69.17M and net income of -$888.00K.

    Revenue and Margins

    The operating margin was -6.9% in the fiscal year ended Dec 2025. Over the 7 years to Dec 2025, revenue grew from $112.31M, a compound annual rate of 15.1%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$300.79M-10.0%65.3%-6.9%-3.2%
    Dec 2024$334.29M-16.0%54.5%-20.3%-8.7%
    Dec 2023$397.99M+8.8%39.0%-32.9%-25.2%
    Dec 2022$365.88M+40.7%68.0%-7.1%12.1%
    Dec 2021$260.09M+118.4%68.6%-15.4%-145.6%
    Dec 2020$119.09M-28.5%56.4%-14.4%-24.5%
    Dec 2019$166.62M+48.4%63.9%8.1%-1.0%
    Dec 2018$112.31MN/A65.0%9.0%-0.3%
    Annual, fiscal years ended Dec 2018 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, the net loss narrowed from the year before. In the quarter ended Sep 2026, the net loss narrowed from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
    Revenue$300.79M$334.29M$397.99M$365.88M$260.09M$119.09M$166.62M$112.31M
    Cost of revenue$104.43M$152.00M$242.88M$117.10M$81.55M$51.89M$60.11M$39.34M
    Gross profit$196.36M$182.30M$155.11M$248.78M$178.54M$67.20M$106.51M$72.97M
    Research and development$5.63M$6.30M$10.10M$8.44M$8.20M$3.41M$4.61M$2.40M
    Operating income-$20.80M-$67.77M-$130.92M-$25.84M-$39.93M-$17.18M$13.46M$10.06M
    Net income-$9.52M-$29.10M-$100.12M$44.22M-$378.76M-$29.18M-$1.64M-$317.00K
    EBITDA$33.42M$1.22M-$72.51M$76.66MN/A-$1.20M$29.32M$21.55M
    Fiscal years ended Dec 2018 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$69.17M$72.11M$64.91M$82.37M$70.66M$78.19M$69.58M$83.50M$78.80M$90.59M$81.40M$96.82M
    Gross profit$47.15M$49.34M$44.44M$53.04M$45.63M$49.11M$48.58M$52.35M$40.65M$40.94M$48.36M$45.69M
    Operating income$4.98M$3.57M-$1.80M$162.00K-$6.24M-$2.70M-$12.02M-$7.16M-$21.52M-$22.11M-$16.99M-$18.36M
    Net income-$888.00K-$2.67M-$6.63M-$8.10M-$11.03M$19.71M-$10.10M-$10.33M-$18.29M$202.00K-$679.00K-$9.40M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, total debt of $364.39M exceeded cash and equivalents by $131.72M.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
    Total assets$499.80M$685.68M$929.11M$1.00B$1.22B$222.84M$226.35MN/A
    Current assets$309.52M$477.12M$698.25M$783.27M$1.00B$59.09M$54.17MN/A
    Cash and equivalents$232.67M$370.06M$523.02M$568.20M$901.89M$9.49M$7.31MN/A
    Total liabilities$438.75M$633.88M$869.72M$836.03M$916.51M$252.79M$227.56MN/A
    Short-term debt$123.96M$0$4.60M$4.96M$3.71M$512.00K$9.07MN/A
    Long-term debt$240.43M$552.20M$738.37M$734.14M$729.91M$216.02M$180.85MN/A
    Shareholder equity$61.06M$51.80M$59.39M$167.05M$302.30M-$29.96M-$1.21MN/A
    Fiscal years ended Dec 2018 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$389.06M$486.57M$473.23M$499.80M$503.64M$507.56M$673.82M$685.68M$699.55M$711.83M$844.74M$929.11M
    Total liabilities$333.31M$431.00M$417.99M$438.75M$437.98M$433.56M$627.76M$633.88M$639.82M$642.64M$781.45M$869.72M
    Cash and equivalents$112.39M$206.07M$204.36M$232.67M$219.40M$212.00M$373.03M$370.06M$358.89M$349.54M$444.63M$523.02M
    Shareholder equity$55.76M$55.57M$55.24M$61.06M$65.66M$74.00M$46.06M$51.80M$59.72M$69.19M$63.30M$59.39M
    Last 12 quarters

    Cash Flow

    In the fiscal year ended Dec 2025, free cash flow was 99.2% of operating cash flow.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
    Operating cash flow$37.48M$16.13M$21.75M-$106.60M-$28.36M-$12.44M$1.73M-$895.00K
    Capital expenditures$303.00K$756.00K$3.83M$10.85M$11.20M$3.50M$8.77M$7.88M
    Free cash flow$37.18M$15.38M$17.93M-$117.45M-$39.56M-$15.94M-$7.05M-$8.78M
    Dividends paidN/AN/AN/AN/AN/A$323.00K$0$98.71M
    Share repurchases$0$0$30.16M$160.00M$0$154.00K$0N/A
    Investing cash flow-$5.16M-$6.79M-$31.51M-$18.87M-$37.73M-$3.82M-$12.48M-$8.44M
    Financing cash flow-$174.93M-$158.34M-$37.45M-$205.24M$959.03M$18.27M$14.58M$11.16M
    Fiscal years ended Dec 2018 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow$11.26M$2.67M-$5.55M$15.20M$9.65M$9.65M$3.00M$16.47M$10.31M$6.20M-$16.85M-$5.17M
    Capital expenditures$93.00K$427.00K$224.00K$139.00K$27.00K$92.00K$45.00K$74.00K$4.00K$334.00K$344.00K$28.00K
    Free cash flow$11.17M$2.24M-$5.78M$15.06M$9.62M$9.55M$2.95M$16.40M$10.31M$5.87M-$17.20M-$5.20M
    Last 12 quarters

    Frequently Asked Questions About SKIN

    What is SkinHealth Systems' annual revenue?

    SkinHealth Systems reported revenue of $300.79M for the fiscal year ended Dec 31, 2025.

    How fast is SkinHealth Systems' revenue growing?

    Revenue was down 10.0% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was -6.3%.

    Is SkinHealth Systems profitable?

    No. SkinHealth Systems reported net income of -$9.52M for the fiscal year ended Dec 31, 2025, with a net margin of -3.2%.

    How much free cash flow does SKIN generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of $37.48M minus capital expenditures of $303.00K produced free cash flow of $37.18M.

    How much debt does SkinHealth Systems have?

    The balance sheet dated Dec 31, 2025 reported long-term debt of $240.43M, short-term debt of $123.96M and cash and equivalents of $232.67M.